Medicamentos OTC, Genéricos y de Marca - FARMACIA DEL NIÑO

SEROQUEL XR (QUETIAPINA) 25 MG 30 TABLETAS

~~$ 1,450.00~~ $ 1,283.97

VAGITROL-V 10 OVULOS

~~$ 723.00~~ $ 578.40

MYSOLINE (PRIMIDONA) 250 MG 50 TAB

$ 742.41

KALIOLITE (CLORURO DE POTASIO) 500 MG 50 GRAGEAS

~~$ 383.24~~ $ 374.61

RELPAX (ELETRIPTAN) 80 MG 2 TAB

~~$ 890.93~~ $ 870.88

RELPAX (ELETRIPTAN) 40 MG 2 TAB

~~$ 651.30~~ $ 608.97

PREMARIN CREMA VAGINAL 43 G

~~$ 1,248.51~~ $ 1,162.98

PREMARIN Crema Vaginal 43 g

Comparable a: Premarin
Sustancia activa: Estrógenos conjugados
Presentación: Tubo con 43 g de crema vaginal
Laboratorio: Wyeth
Origen: México

Este medicamento se utiliza para el tratamiento de los síntomas vaginales asociados a la menopausia, como sequedad, picazón y dolor durante las relaciones sexuales. Los estrógenos conjugados ayudan a restaurar la mucosa vaginal y mejorar la lubricación y elasticidad de los tejidos.

El consumo de este producto es responsabilidad de quien lo recomienda y quien lo usa. Consulte a su médico antes de consumir cualquier medicamento.

THERAPEUTIC INDICATIONS: * Premarin vaginal cream is indicated for the treatment of vulvar atrophy, vaginal and vulvar kraurosis.

Contraindications: Suspected or confirmed pregnancy (see Restrictions of use during pregnancy and lactation).

Undiagnosed abnormal bleeding.

Suspected or confirmed estrogen-dependent neoplasia (eg endometrial cancer, endometrial hyperplasia).

History of active arterial thromboembolic disease (eg stroke, myocardial infarction) or deep thromboembolism (such as deep vein thrombosis, pulmonary embolism).

Dysfunction or active liver disease or chronic.

Known or suspected hypersensitivity to ingredients.

GENERAL PRECAUTIONS: Systemic absorption can occur with the use of vaginal cream with ECE. It must take into account the precautions and warnings associated with the oral treatment of ECE.

Fluid retention: Since estrogen / progestin may cause a degree of fluid retention in patients with conditions that can be influenced by this factor, such as cardiac or renal dysfunction, ensure careful observation when estrogens are prescribed.

In the study of health and osteoporosis, progestin and estrogen (HOPE), the mean increases from baseline in serum triglycerides after one year of treatment with CEE 0.625, 0.45 and 0.3 mg compared with placebo were 34.3,30.2 , 25.1, and 10.7 respectively.

Impaired liver function: Patients with impaired liver function may metabolize poorly estrogen / progestin.

History of cholestatic jaundice: For patients with a history of cholestatic jaundice associated with past use of estrogen or pregnancy, caution should be exercised, and in case of recurrence, medication should be discontinued.

DOSAGE AND ADMINISTRATION: The Administration should be cyclic (eg, three weeks of application and one week off) and only for short periods.

You must select the lowest dose that controls your symptoms and should be discontinued ifsymptoms persist.

Usual dose range: ½ to two grams a day, vaginally, depending on the severity of the condition. Ensure that the discontinuation or reduction of medication takes place at intervals of 3 to 6 months.

Concomitant progestogen: The addition of a progestin during the administration of estrogenreduces the risk of endometrial hyperplasia and carcinoma, which has been associated withlong-term use of unopposed estrogen.

Morphological and biochemical studies of endometrium suggest that you need to manage for 10 to 14 days to provide maximum maturation of the endometrium in order to eliminate anyhyperplastic alteration.

Since progestogens are administered to protect against endometrial hyperplastic changes, patients without a uterus may not need a progestin. Administration should be cyclic (eg, three weeks of treatment and rest) and only for short-term therapy.

Patients should be reevaluated periodically to determine whether treatment of the symptomsis still necessary.